Powering cohort research to stop dementia before it starts
Unprecedented access to cohort data
The Data Portal offers scientists around the world a secure online environment to work with some of the richest cohort data optimised for dementia research.
Our newsletter features latest findings, data updates and funding opportunities for dementia research.
6 February 2020
The New therapeutics in Alzheimer's Disease (NTAD) study, supported by Dementias Platform UK (DPUK), is testing new brain scans that are revealing early changes in the brain that are a signature of Alzheimer’s disease. These markers for the disease will be used to test whether experimental treatments can delay, or even prevent, the progression of the disease.